CORC  > 武汉大学
JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4(+) T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease
Zhou, Rui; Chang, Ying; Liu, Jing; Chen, Min; Wang, Hongling; Huang, Meifang; Liu, Shi; Wang, Xiaobing; Zhao, Qiu
刊名FRONTIERS IN IMMUNOLOGY
2017
卷号8
关键词JNK pathway-associated phosphatase inflammatory bowel disease CD4(+) T cell activation proliferation
ISSN号1664-3224
DOI10.3389/fimmu.2017.00781
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4050174
专题武汉大学
推荐引用方式
GB/T 7714
Zhou, Rui,Chang, Ying,Liu, Jing,et al. JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4(+) T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease[J]. FRONTIERS IN IMMUNOLOGY,2017,8.
APA Zhou, Rui.,Chang, Ying.,Liu, Jing.,Chen, Min.,Wang, Hongling.,...&Zhao, Qiu.(2017).JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4(+) T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease.FRONTIERS IN IMMUNOLOGY,8.
MLA Zhou, Rui,et al."JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4(+) T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease".FRONTIERS IN IMMUNOLOGY 8(2017).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace